Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Baricitinib is effective and safe for treating severe alopecia areata for up to 5 years.

Deferasirox effectively reduces iron overload in ß-thalassemia patients but may cause some manageable side effects.

Topical tofacitinib may effectively and safely regrow facial hair in some people with alopecia areata.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Fludalanine failed as an effective oral antibiotic despite efforts.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

Bicalutamide, a drug with a good safety profile, is a promising new treatment for female pattern hair loss.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Tofacitinib may help regrow hair in alopecia areata patients.

Oral dutasteride and topical pimecrolimus can safely and effectively treat Frontal Fibrosing Alopecia, leading to significant hair regrowth.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Mesotherapy with bicalutamide has limited effectiveness for female hair loss.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

Oral dutasteride can potentially treat frontal fibrosing alopecia in postmenopausal women, with some patients showing disease arrest and hair regrowth.

There are various treatment options for frontal fibrosing alopecia.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Terbinafine and itraconazole are more effective against Microsporum canis than fluconazole and griseofulvin.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

Oral tofacitinib successfully treated a girl's severe skin and hair conditions.

Ezetimibe effectively reduces prostate size in cases of benign prostatic hyperplasia.

Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.

Tofacitinib and baricitinib are similarly effective and safe for alopecia areata, but baricitinib works faster.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.